R. Al-Qazazi

Excess Protein O-GlcNAcylation Links Metabolic Derangements to Right Ventricular Dysfunction in Pulmonary Arterial Hypertension

S. Archer, F. Potus, T. Thenappan, 2020, International journal of molecular sciences.

An integrated proteomic and transcriptomic signature of the failing right ventricle in monocrotaline induced pulmonary arterial hypertension in male rats

Charles T. Hindmarch, F. Potus, P. Xiong, 2022, Frontiers in Physiology.

PINK1‐induced phosphorylation of mitofusin 2 at serine 442 causes its proteasomal degradation and promotes cell proliferation in lung cancer and pulmonary arterial hypertension

S. Archer, F. Potus, S. Bonnet, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia

D. Falzarano, A. Banerjee, G. Evans, 2022, Redox Biology.

Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer.

S. Archer, J. Mewburn, L. Tian, 2021, Free radical biology & medicine.

Macrophage–NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension

F. Potus, S. Provencher, S. Bonnet, 2022, American journal of respiratory and critical care medicine.

Mitochondria in human neutrophils mediate killing of Staphylococcus aureus

P. Kubes, B. Surewaard, J. Mewburn, 2021, Redox biology.